scholarly journals Development and validation of a clinicopathological‐based nomogram to predict seeding risk after percutaneous thermal ablation of primary liver carcinoma

2020 ◽  
Vol 9 (18) ◽  
pp. 6497-6506
Author(s):  
Chao An ◽  
Zhimei Huang ◽  
Jiayan Ni ◽  
Mengxuan Zuo ◽  
Yiquan Jiang ◽  
...  
2014 ◽  
Vol 35 (10) ◽  
pp. 1045
Author(s):  
Jian-quan ZHANG ◽  
Jian-guo SHENG ◽  
Zong-ping DIAO ◽  
Lu-lu ZHAO ◽  
Hang ZHANG

2019 ◽  
Vol 49 (6) ◽  
pp. 711-717 ◽  
Author(s):  
Kazuki Ohya ◽  
Satoshi Saitoh ◽  
Shunichiro Fujiyama ◽  
Yusuke Kawamura ◽  
Hitomi Sezaki ◽  
...  

2018 ◽  
Vol 42 (3) ◽  
pp. 344-357 ◽  
Author(s):  
Julien Garnon ◽  
Roberto Luigi Cazzato ◽  
Jean Caudrelier ◽  
Maud Nouri-Neuville ◽  
Pramod Rao ◽  
...  

2006 ◽  
Vol 30 (1) ◽  
pp. 130-135 ◽  
Author(s):  
Emilie Lermite ◽  
Jérôme Lebigot ◽  
Frédéric Oberti ◽  
Patrick Pessaux ◽  
Christophe Aube ◽  
...  

1957 ◽  
Vol 11 (4) ◽  
pp. 523-534 ◽  
Author(s):  
P E Steiner ◽  
J N P Davies

2018 ◽  
Vol 35 (04) ◽  
pp. 299-308 ◽  
Author(s):  
A. Kurup ◽  
Matthew Callstrom ◽  
Michael Moynagh

AbstractImage-guided, minimally invasive, percutaneous thermal ablation of bone metastases has unique advantages compared with surgery or radiation therapy. Thermal ablation of osseous metastases may result in significant pain palliation, prevention of skeletal-related events, and durable local tumor control. This article will describe current thermal ablation techniques utilized to treat bone metastases, summarize contemporary evidence supporting such thermal ablation treatments, and outline an approach to percutaneous ablative treatment.


Sign in / Sign up

Export Citation Format

Share Document